• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

头孢匹胺纸片药敏试验的解释标准和质量控制指南。

Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.

作者信息

Barry A L, Gavan T L, Thornsberry C, Jones R N

出版信息

J Clin Microbiol. 1985 Oct;22(4):688-90. doi: 10.1128/jcm.22.4.688-690.1985.

DOI:10.1128/jcm.22.4.688-690.1985
PMID:4077974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC268499/
Abstract

Disk susceptibility tests with 30- and 75-micrograms cefpiramide disks were evaluated with 614 bacterial isolates. Quality control parameters were also evaluated, and control limits for disk tests are recommended. Tests with 75-micrograms disks are recommended, with zone size standards of greater than or equal to 19 mm for susceptible (MIC, less than or equal to 32 micrograms/ml) and less than or equal to 15 mm for resistant (MIC, greater than or equal to 128 micrograms/ml).

摘要

使用614株细菌分离株对含30微克和75微克头孢匹胺纸片的纸片药敏试验进行了评估。还评估了质量控制参数，并推荐了纸片试验的控制限度。推荐使用75微克纸片进行试验，敏感（最低抑菌浓度，小于或等于32微克/毫升）的抑菌圈大小标准为大于或等于19毫米，耐药（最低抑菌浓度，大于或等于128微克/毫升）的抑菌圈大小标准为小于或等于15毫米。

相似文献

1
Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.头孢匹胺纸片药敏试验的解释标准和质量控制指南。
J Clin Microbiol. 1985 Oct;22(4):688-90. doi: 10.1128/jcm.22.4.688-690.1985.
2
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks.环丙沙星纸片药敏试验：5微克纸片的解释性抑菌圈大小标准
J Clin Microbiol. 1985 Jun;21(6):880-3. doi: 10.1128/jcm.21.6.880-883.1985.
3
Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.头孢布烯纸片药敏试验的解释标准及质量控制限度。抗菌药物敏感性协作试验组。
J Clin Microbiol. 1990 Mar;28(3):605-7. doi: 10.1128/jcm.28.3.605-607.1990.
4
Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.头孢哌酮纸片扩散法药敏试验：暂定解释标准的确认、铜绿假单胞菌交叉耐药性及质量控制性能限度的测定
J Clin Microbiol. 1982 May;15(5):777-86. doi: 10.1128/jcm.15.5.777-786.1982.
5
Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.阿洛西林纸片药敏试验的解释标准及暂定质量控制限度
J Clin Microbiol. 1984 Jun;19(6):777-82. doi: 10.1128/jcm.19.6.777-782.1984.
6
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.新型口服头孢菌素BMY-28100的纸片扩散药敏试验及肉汤微量稀释法质量控制指南
J Clin Microbiol. 1987 Nov;25(11):2211-3. doi: 10.1128/jcm.25.11.2211-2213.1987.
7
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.头孢噻肟：体外活性及纸片药敏试验的初步解释标准
Antimicrob Agents Chemother. 1980 Jul;18(1):88-93. doi: 10.1128/AAC.18.1.88.
8
Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.头孢磺啶：纸片药敏试验的抗菌活性及暂行解释性抑菌圈标准
Antimicrob Agents Chemother. 1981 Oct;20(4):525-9. doi: 10.1128/AAC.20.4.525.
9
Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.氨曲南：抗菌活性、β-内酰胺酶稳定性以及纸片扩散法药敏试验的解释标准和质量控制指南
Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S594-604. doi: 10.1093/clinids/7.supplement_4.s594.
10
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.临床微生物实验室中第四代头孢菌素HR810的纸片扩散法检测、质量控制指南及抗菌谱
J Clin Microbiol. 1984 Sep;20(3):409-12. doi: 10.1128/jcm.20.3.409-412.1984.

本文引用的文献

1
Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.与其他广谱头孢菌素相比，SM-1652的抗菌活性。
Antimicrob Agents Chemother. 1982 Nov;22(5):721-7. doi: 10.1128/AAC.22.5.721.
2
Pharmacokinetics of cefpiramide (SM-1652) in humans.头孢匹胺（SM-1652）在人体内的药代动力学。
Antimicrob Agents Chemother. 1984 Feb;25(2):221-5. doi: 10.1128/AAC.25.2.221.
3
Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.头孢匹胺与阿洛西林对厌氧菌的体外比较活性
Antimicrob Agents Chemother. 1984 Feb;25(2):162-4. doi: 10.1128/AAC.25.2.162.
4
In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.具有抗假单胞菌活性的新型广谱头孢菌素SM-1652的体外抗菌活性
Antimicrob Agents Chemother. 1983 Feb;23(2):195-200. doi: 10.1128/AAC.23.2.195.
5
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.氨苄西林、羧苄西林、美洛西林和哌拉西林纸片扩散药敏试验的质量控制限度：一项协作研究。
J Clin Microbiol. 1981 Jul;14(1):67-72. doi: 10.1128/jcm.14.1.67-72.1981.
6
In vitro antibacterial activity of cefpiramide.头孢匹胺的体外抗菌活性。
Antimicrob Agents Chemother. 1984 Mar;25(3):368-72. doi: 10.1128/AAC.25.3.368.